Cardiol Therapeutics Inc share price logo

Cardiol Therapeutics Inc Share Price

NASDAQ: CRDL

Small Cap

$1.39

+0.01

(+0.36%)

as on

Cardiol Therapeutics Inc Stock Performance

as on April 11, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.37
    $1.44
    downward going graph

    1.44%

    Downside

    3.60%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.87
    $1.59
    downward going graph

    37.22%

    Downside

    14.39%

    Upside

    downward going graph

Cardiol Therapeutics Inc share price movements today

Previous Close
$1.38
Open
$1.38
Volume
1.2M
Day's Low - High
$1.37 - $1.44
52 Week Low - High
$0.87 - $1.59

Cardiol Therapeutics Inc Historical Returns

1 Month Return
+ 27.78 %
3 Month Return
+ 38.37 %
1 Year Return
+ 44.2 %
3 Year Return
+ 116.88 %
5 Year Return
0 %

Cardiol Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cardiol Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$154.1M

EPS (TTM)

-0.3767

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-34.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-158.75%

Cardiol Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiol Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cardiol Therapeutics Inc image
Cardiol Therapeutics Inc
BUY$154.1MNANA0.00%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.1BNA20.5141.94%
Viatris Inc. image
Viatris Inc.
HOLD$15.8B0.56%-21.95-24.58%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.6BNA20.0215.11%
Zoetis Inc. image
Zoetis Inc.
BUY$50.7B-26.27%19.8728.24%

Stock Returns calculator for Cardiol Therapeutics Inc Stock including INR - Dollar returns

The Cardiol Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cardiol Therapeutics Inc investment value today

Current value as on today

₹1,56,294

Returns

₹56,294

(+56.29%)

Returns from Cardiol Therapeutics Inc Stock

₹44,792 (+44.79%)

Dollar Impact

₹11,503 (+11.5%)

Analyst Recommendation on Cardiol Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cardiol Therapeutics Inc. Average target price of $7.44

Cardiol Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cardiol Therapeutics Inc.

What analysts predicted

81.32%UPSIDE

Target Price

$7.44

Current Price

$1.39

Analyzed by

8 Analysts

Target

$7.44

Cardiol Therapeutics Inc target price $7.44, a slight upside of 81.32% compared to current price of $1.39. According to 8 analysts rating.

Cardiol Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Cardiol Therapeutics Inc Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-15% versus previous 30 day period

Cardiol Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
0
0
-
0
-
-
-
0
Operating Income
-5
-8
-8
-5
-14
-6
-8
-7
-10
-8
EBITDA
-4
-
-8
-4
-13
-5
-8
-7
-9
-8
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-7
-9
-4
-12
-5
-8
-8
-9
-7
Income Tax Expense
-1
-
0
0
-
-
-
-
-
-
Net Income
-3
-5
-6
-3
-9
-3
-5
-8
-9
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
-
-
Operating Income
-7
-10
-16
-30
-30
-22
-40
-34
EBITDA
-7
-10
-16
-24
-22
-21
-40
-34
Interest Expense
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-15
-10
-16
-25
-22
-21
-36
-33
Income Tax Expense
0
0
0
-6
-10
0
-
-
Net Income
-11
-8
-12
-19
-16
-15
-25
-33
Net Profit Margin
0.00%
0.00%
-20570.94%
-40170.87%
0.00%
0.00%
0.00%
0.00%

Cardiol Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-7
-9
-6
-12
-8
-8
-8
-9
-7
Operating Cash Flow
-6
-6
-4
-7
-5
-7
-4
-6
-5
Investing Cash Flow
-
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
18
0
0
0
15
Change in Cash
-6
-6
-4
-8
14
-7
-5
-6
9

Cardiol Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-13
-20
-31
-30
-28
-36
-33
Operating Cash Flow
-10
-11
-9
-23
-27
-25
-25
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
25
2
16
93
0
0
18
15
Change in Cash
14
-9
7
69
-24
-24
-4
-9

Global Institutional Holdings in Cardiol Therapeutics Inc

Funds
Holdings
INTEGRITY ALLIANCE, LLC.
0.39%
AdvisorShares Investments, LLC
0.5%
Morgan Stanley - Brokerage Accounts
0.14%
Virtu Financial LLC
0.13%
Atria Investments LLC
0.12%
See all

Cardiol Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:15 PM

    -

    Cardiol Therapeutics receives U.S. patent allowance for CardiolRx™ and CRD-38, extending protection until late 2040.

Insights on Cardiol Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CRDL stock has moved up by 31.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 153.2% return, outperforming this stock by 3.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 103.3% return, outperforming this stock by 59.1%

About Cardiol Therapeutics Inc

cardiol therapeutics is a nanotherapeutics company focused on the research and commercial development of proprietary drug formulations for the treatment of heart failure. heart failure is a chronic condition that affects more than 26 million people globally. over five million adults in the u.s. suffer from heart failure, and it remains a leading cause of death and hospitalization with associated healthcare costs exceeding $30 billion annually. people with heart failure experience shortness of breath, fatigue, rapid heart rate, edema, reduced exercise capacity and a marked reduction in quality of life. approximately half of all heart failure patients have heart failure with preserved ejection fraction (hfpef), which is often associated with diabetes, obesity and high blood pressure and for which there have been no new therapies developed in over 20 years. cardiol is developing ctx01, a proprietary nanoformulation of pharmaceutical cannabidiol for the treatment of hfpef. cannabidiol has
OrganisationCardiol Therapeutics Inc
Headquarters2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5
CEOMr. David G. Elsley MBA
E-voting on sharesClick here to vote

Key Management of Cardiol Therapeutics Inc

Name

Title

Mr. David G. Elsley MBA

President, CEO & Director

Mr. Bernard Lim B.Sc.

Chief Operating Officer

Dr. Andrew Warwick Hamer M.D.

Chief Medical Officer and Head of Research & Development

Trevor Burns

Investor Relations

Mr. John A. Geddes BSCPT, MBA

Vice President of Corporate Development

FAQs

What is Cardiol Therapeutics Inc share price today?

Cardiol Therapeutics Inc share price today is $1.39 as on at the close of the market. Cardiol Therapeutics Inc share today touched a day high of $1.44 and a low of $1.37.

What is the 52 week high and 52 week low for Cardiol Therapeutics Inc share?

Cardiol Therapeutics Inc share touched a 52 week high of $1.59 on and a 52 week low of $0.87 on . Cardiol Therapeutics Inc stock price today i.e. is closed at $1.39,which is 12.58% down from its 52 week high and 59.28% up from its 52 week low.

What is Cardiol Therapeutics Inc's market capitalisation today?

Cardiol Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Cardiol Therapeutics Inc Stock (CRDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cardiol Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiol Therapeutics Inc Shares that will get you 1.0791 shares as per Cardiol Therapeutics Inc share price of $1.39 per share as on April 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cardiol Therapeutics Inc Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics Inc (CRDL) shares with as little as ₹93.048 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.48 in Cardiol Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cardiol Therapeutics Inc share’s latest price of $1.39 as on April 11, 2026 at 1:29 am IST, you will get 7.1942 shares of Cardiol Therapeutics Inc. Learn more about fractional shares .